Comparison

CHIR-98014 European Partner

Item no. TMO-T2608-100mg
Manufacturer TargetMol
CASRN 252935-94-7
Amount 100 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Ring DB,et al. Diabetes. 2003, 52(3), 588-595.
Smiles ClC1=C(C=2C(=CN=C(NCCNC=3N=C(N)C(N(=O)=O)=CC3)N2)N4C=CN=C4)C=CC(Cl)=C1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias CHIR 98014,CT98014,CHIR98014
Shipping Condition Cool pack
Available
Manufacturer - Targets
GSK-3|||FGFR|||S6 Kinase|||Src
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
486.31
Description
CHIR-98014 (CT98014) is a selective GSK3 inhibitor; potentiate insulin activation of glucose transport and utilization in vitro and in vivo.
Pathways
PI3K/Akt/mTOR signaling|||Angiogenesis|||Tyrosine Kinase/Adaptors|||MAPK|||Stem Cells

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close